Hatch BioFund
Venture capitalDoylestown
Fund manager profile
Hatch BioFund is a venture fund manager based in Doylestown. SEC filings show 1 venture fund on record, most recently Hatch BioFund, LP ($50M offering) filed May 2023.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 2 of 2 portfolio companiesBiotech ×2Deep Tech ×1Healthtech ×1
HQs:United States×1
Investments · 2 tracked
founders shown can be your intro path
Optimeos develops a nanoparticle-based drug formulation and delivery platform (CINCs and LINCs) for complex biologics including mRNA, DNA, peptides, and proteins, targeting rare diseases, immunology, and metabolic conditions such as obesity.
BiotechDeep TechHealthtech
Bob Prud'homme(Leadership (PhD))Rob Pagels(Leadership (PhD))Chet Markwalter(Leadership (PhD))Shahram Hejazi(Leadership (PhD))Gregory Harriman(Leadership (MD))Mark Esposito(Leadership (PhD))
Co-investors7G BioVenturesAnzu Partners
BiotechPrinceton, US
Robert K. Prud'homme, PhD(Director)Shahram Hejazi, PhD(Executive Officer, Director)
BoardBenjamin Doranz(Director)Jason Smith, PhD(Director)
Portfolio news
latest coverage across their companiesOptimeos · mychesco.com · Jul 6, 2026
Optimeos Life Sciences · mychesco.com · Jul 6, 2026
Frequently asked questions
- Where is Hatch BioFund located?
- Hatch BioFund is headquartered in Doylestown, US.